Back to
Creative Planning
ACRS
Showing 4 of 12 quarters
Position history for
Creative Planning's holdings in Aclaris Therapeutics, Inc.
Yes. Creative Planning holds 258,367 shares of ACRS (Aclaris Therapeutics), worth $1.4M, as of its Q3 2026 13F filing. It increased the position by 51,720 shares (+25.0%) from Q2 2026. Creative Planning has held ACRS since Q4 2025, across 4 quarterly 13F filings.
Current Value
$1.4M
Current Shares
258,367
Total Value Change
+$1.2M
Total Shares Change
+207,196
Quarter-by-Quarter History